X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (196) 196
oncology (166) 166
female (124) 124
male (121) 121
middle aged (118) 118
aged (111) 111
index medicus (93) 93
cancer (90) 90
adult (89) 89
chemotherapy (81) 81
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
colorectal cancer (72) 72
treatment outcome (58) 58
fluorouracil - administration & dosage (53) 53
fluorouracil (52) 52
colorectal neoplasms - drug therapy (51) 51
life sciences (47) 47
colorectal neoplasms - pathology (44) 44
metastasis (44) 44
adenocarcinoma - drug therapy (43) 43
irinotecan (43) 43
camptothecin - analogs & derivatives (40) 40
oxaliplatin (39) 39
leucovorin (38) 38
therapy (38) 38
leucovorin - administration & dosage (35) 35
survival (35) 35
disease-free survival (34) 34
aged, 80 and over (33) 33
adenocarcinoma (32) 32
antineoplastic combined chemotherapy protocols - adverse effects (32) 32
hematology, oncology and palliative medicine (32) 32
camptothecin - administration & dosage (31) 31
combined modality therapy (31) 31
neoplasm metastasis (30) 30
prospective studies (30) 30
survival rate (30) 30
carcinoma (29) 29
liver neoplasms - secondary (28) 28
5-fluorouracil (27) 27
antineoplastic agents - therapeutic use (26) 26
1st-line treatment (25) 25
prognosis (25) 25
surgery (25) 25
neoplasm staging (24) 24
liver metastases (23) 23
care and treatment (22) 22
trial (22) 22
adenocarcinoma - mortality (21) 21
cetuximab (21) 21
colorectal neoplasms - genetics (21) 21
drug administration schedule (21) 21
follow-up studies (21) 21
organoplatinum compounds - administration & dosage (21) 21
pancreatic neoplasms - drug therapy (21) 21
time factors (21) 21
adenocarcinoma - secondary (20) 20
deoxycytidine - analogs & derivatives (20) 20
gastroenterology & hepatology (20) 20
mutation (20) 20
adenocarcinoma - surgery (19) 19
chemotherapy, adjuvant (19) 19
fluorouracil - therapeutic use (19) 19
medicine & public health (19) 19
radiotherapy (19) 19
adenocarcinoma - radiotherapy (18) 18
colorectal neoplasms (18) 18
survival analysis (18) 18
tumors (18) 18
adenocarcinoma - pathology (17) 17
cisplatin (17) 17
liver neoplasms - drug therapy (17) 17
pancreatic cancer (17) 17
research (17) 17
bevacizumab (16) 16
cisplatin - administration & dosage (16) 16
colorectal-cancer (16) 16
combination (16) 16
disease progression (16) 16
fluorouracil - adverse effects (16) 16
france (16) 16
gemcitabine (16) 16
randomized-trial (16) 16
stomach neoplasms - drug therapy (16) 16
[sdv.can]life sciences [q-bio]/cancer (15) 15
animals (15) 15
phase-ii (15) 15
phase-ii trial (15) 15
stomach neoplasms - surgery (15) 15
[ sdv.can ] life sciences [q-bio]/cancer (14) 14
capecitabine (14) 14
colorectal neoplasms - mortality (14) 14
metastases (14) 14
metastatic colorectal cancer (14) 14
mice (14) 14
retrospective studies (14) 14
analysis (13) 13
antineoplastic combined chemotherapy protocols - administration & dosage (13) 13
camptothecin - therapeutic use (13) 13
continuous-infusion (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2015, Volume 26, Issue suppl 4, pp. iv45 - iv45
Journal Article
by Kubicka Prof, Stefan and Greil, R and André, T and Bennouna, J and Sastre, J and Van Cutsem, E and Von Moos, R and Österlund, P and Reyes-Rivera, I and Müller, T and Makrutzki, M and Arnold, D and Andel, J and Balcke, P and Benedicic, B and Eisterer, W and Fridrik, M and Jagdt, B and Keil, F and Kretschmer, A and Krippl, P and Oexle, H and Pecherstorfer, M and Samonigg, H and Schmid, M and Thaler, J and Tinchon, C and Weiss, H and Arts, J and De Man, M and Demolin, G and Janssens, J and Polus, M and Benczikova, B and Melichar, B and Prausova, J and Vitek, P and Andersen, F.Z and Jensen, B.B and Keldsen, N and Østerlind, K and Vistisen, K and Elme, A and Magi, A and Ojamaa, K and Ristamäki, R and Salminen, T and Ben Abdelghani, M and Bouche, O and Borg, C and Bouhier-Leporrier, K and Breysacher, G and Chone, L and Clavero Fabri, M.-C and Deplanque, G and Desseigne, F and Dourthe, L.-M and Ezenfis, J and Faroux, R and François, E and Garnier, C and Gaspard, M.-H and Hebbar, M and Illory, J.F and Kaminsky, M.-C and Lecomte, T and Legoux, J.-L and Levache, B and Lobry, C and Lotz, J.-P and Mabro, M and Manet-Lacombe, S and Manfredi, S and Matysiak Budnik, T and Miglianico, L and Mineur, L and Moullet, I and Naman, H and Nouyrigat, P and Oziel-Taieb, S and Perrier, H and Pezet, D and Philip, J and Pottier, V and Porneuf, M and Ramdani, M and Re, D and Rinaldi, Y and Spaeth, D and Taieb, J and Terrebonne, E and Texereau, P and Thirot Bidault, A and Tournigand, C and Tubiana-Mathieu, N and Vantelon, J.-M and Viret, F and Ychou, M and Bangerter, M and Bertram, M.E and ...
Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2342 - 2349
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2342 - 2349
Journal Article
Surgery, ISSN 0039-6060, 02/2019, Volume 165, Issue 2, pp. 476 - 484
The impact of the location of colorectal cancer on patient outcomes has been reported in several settings. The objective of this study was to assess the... 
ADJUVANT CHEMOTHERAPY | SURVIVAL | SURGERY | CETUXIMAB | SITE | MUTATION STATUS | COLORECTAL-CANCER | STAGE | RECURRENCE | PRIMARY TUMOR LOCATION | HEPATIC RESECTION
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 06/2017, Volume 36, Issue 1, pp. 89 - 13
Background: Metastatic colorectal cancer (mCRC) is one of the major causes of cancer-related death. Despite the substantial progress in mCRC management, it... 
Metastatic | Antibody | Targeted therapy | Claudin-1 | Colorectal cancer | LEUCOVORIN | METASTASIS | PLUS IRINOTECAN | PROLIFERATION | FLUOROURACIL | OVEREXPRESSION | CETUXIMAB | ONCOLOGY | SEQUENCE | TIGHT JUNCTION PROTEINS | EXPRESSION | Claudin-1 - antagonists & inhibitors | Intestinal Mucosa - metabolism | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Cell Survival - genetics | Gene Expression Profiling | Molecular Targeted Therapy | Biomarkers, Tumor | Intestinal Mucosa - drug effects | Neoplasm Metastasis | Colorectal Neoplasms - drug therapy | Female | Retrospective Studies | Colorectal Neoplasms - metabolism | Disease Models, Animal | Colorectal Neoplasms - mortality | Antibodies, Monoclonal - pharmacology | Antineoplastic Agents, Immunological - pharmacology | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Single Photon Emission Computed Tomography Computed Tomography - methods | Cell Cycle - drug effects | Colorectal Neoplasms - pathology | Neoplasm Staging | Intestinal Mucosa - pathology | Viral antibodies | Cellular proteins | Care and treatment | Analysis | Antibodies | Research | Proteins | Epidermal growth factor | Pancreatic cancer | Medical prognosis | Melanoma | Tumorigenesis | Metastasis | Gene expression | Experiments | Apoptosis | Cell adhesion & migration | Life Sciences
Journal Article
Nature Medicine, ISSN 1078-8956, 2014, Volume 20, Issue 4, pp. 430 - 435
Journal Article
Annals of Oncology, ISSN 0923-7534, 04/2015, Volume 26, Issue 4, pp. 822 - 825
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2013, Volume 24, Issue suppl 9, pp. ix14 - ix14
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 04/2015, Volume 26, Issue 4, pp. 822 - 825
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 7/2012, Volume 20, Issue 7, pp. 1395 - 1404
Journal Article